Results 91 to 100 of about 2,541 (178)

Correction: Burden of Disease and Treatment Gap in Patients with an Osteoporotic Hip Fracture between 2015 and 2019 in Italy. [PDF]

Drugs Aging
Scortichini M, Dilecce M, Spelta M, Sammak S, Riegler S, Bartolini F, Sciattella P.   +6 more
europepmc   +1 more source

Publisher Correction: Pricing for Multi-Indication Drugs in the Italian Regulatory Context. [PDF]

Pharmacoecon Open
Ursino MG, Milano A, De Angelis FV, Alessi E, Trotta F.   +4 more
europepmc   +1 more source

Parents' preference for the inclusion of pediatric vaccines in the Chinese National Immunization Program: A discrete choice experiment. [PDF]

Hum Vaccin Immunother
Wang X, Sun Y, Wang J, Jing Z, Ding B, Yao H, Zhang L, Li X.   +7 more
europepmc   +1 more source

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country. [PDF]

PLoS One
Do TX, Nguyen HT, Nguyen PTL, Kieu MTT, Duong TV, Pham VNH.   +5 more
europepmc   +1 more source

Awareness and Sociodemographic Factors as Predictors of Knowledge About Health Economics and Pharmacoeconomics Among Registered Nurses: A Cross-Sectional Study. [PDF]

Clinicoecon Outcomes Res
Alanazi HI, Tumala RB, Asiri MY, Alharbi HA, Alenazy BA, Al-Ghareeb SA, Alsmari AA, Alsbaie MA.   +7 more
europepmc   +1 more source

Impact of Chinese national centralized volume-based drug procurement policy on health costs and utilization: An interrupted time series analysis using panel data (2009-2022). [PDF]

PLoS One
Jiang Y, Wan G, Shi Y, Pu G, Shao X.
europepmc   +1 more source

Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis. [PDF]

PLoS One
Chen Q, Chen T, Lin W, Chen X.
europepmc   +1 more source

A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spain

ClinicoEconomics and Outcomes Research
Ana Fernández,1,* Beatriz González Astorga,2,* Nuria Rodríguez,3,* María José Safont,4,* Paula Castro Albarrán,5 María Mareque,5 Itziar Oyagüez5 1Medical Oncology Department, Ourense University Hospital Complex, Ourense ...
Fernández A, González Astorga B, Rodríguez N, Safont MJ, Castro Albarrán P, Mareque M, Oyagüez I   +6 more
doaj  

The dynamic field of pharmacoeconomics

Expert Review of Clinical Pharmacology, 2009
M. Postma
semanticscholar   +1 more source

Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs. [PDF]

Pharmacoecon Open
García-Díaz M, Mestre-Ferrándiz J, Espín J.   +2 more
europepmc   +1 more source